Assessment of driving performance in patients with relapsing-remitting multiple sclerosis during 24-month therapy with interferon beta-1a

被引：0
|
作者：
Stueckle, KF [1 ]
Sindern, E [1 ]
Kotterba, S [1 ]
机构：
[1] Univ Hosp Bergmannsheil, Bochum, Germany
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [11] Effect of Intramuscular Interferon beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis
    Nakamura, Kunio
    Rudick, Richard
    Lee, Jar-Chi
    Foulds, Pamela
    Fisher, Elizabeth
    NEUROLOGY, 2010, 74 (09) : A407 - A407
  • [12] Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis
    De Stefano, Nicola
    Curtin, Francois
    Stubinski, Bettina
    Blevins, Gregg
    Drulovic, Jelena
    Issard, Delphine
    Shotekov, Penko
    Gasperini, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 888 - 892
  • [13] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Dupuy, Sheena L.
    Khalid, Fariha
    Healy, Brian C.
    Bakshi, Sonya
    Neema, Mohit
    Tauhid, Shahamat
    Bakshi, Rohit
    BMC MEDICAL IMAGING, 2016, 16
  • [14] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Dupuy, S.
    Khalid, F.
    Healy, B. C.
    Bakshi, S.
    Neema, M.
    Tauhid, S.
    Bakshi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 232 - 232
  • [15] Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
    Foley, John F.
    Barnes, Christopher J.
    Nair, Kavita V.
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : S16 - S23
  • [16] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Sheena L. Dupuy
    Fariha Khalid
    Brian C. Healy
    Sonya Bakshi
    Mohit Neema
    Shahamat Tauhid
    Rohit Bakshi
    BMC Medical Imaging, 16
  • [17] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [18] Influence of histocompatibility genes on the clinical course of patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a
    Fletcher, S.
    Klein, T.
    Pollak, L.
    MULTIPLE SCLEROSIS, 2007, 13 : S200 - S201
  • [19] Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Sheridan M. Hoy
    CNS Drugs, 2015, 29 : 171 - 179
  • [20] Longitudinal Assessment of Optical Coherence Tomography in Patients with Relapsing -Remitting Multiple Sclerosis on Interferon beta-1a
    Wong, Ka-Ho
    Bacharach, Rae
    Fjeldstad, Anette
    Klein, Julia
    Soldan, M. Paz
    Rose, John
    NEUROLOGY, 2022, 98 (18)
12345